Navigation Links
SMI Expands Eye Tracking Business with Office in San Francisco

SAN FRANCISCO, BERLIN and TETLOW, Germany, December 27, 2013 /PRNewswire/ --

On January 1st 2014, SensoMotoric Instruments (SMI) opens an office in San Francisco to focus on eye tracking integration in consumer and industrial applications and to be close to leading Universities in scientific research eye tracking

SensoMotoric Instruments (SMI), a leader in eye tracking technology and application, expands its presence in California with a new office in San Francisco. Having an office in California, the hub of high-tech businesses, allows SMI to lay a stronger focus on the growing opportunities with OEM partners in consumer and industrial gaze based interaction applications and with end users in scientific and research applications. The new presence will play an essential role in serving key SMI customers located at the West Coast including Stanford University, Google, Cisco, Intel, Microsoft, HP, Boeing, Sony, Qualcomm, and many more.

After selling its OEM Ophthalmic business unit to Alcon, leader in medical eye care, SensoMotoric Instruments has been growing rapidly due to its leading eye tracking technology solutions and longstanding relationship with best in class partners. SMI has a long track record of innovative product developments. Two years ago, SMI revolutionized the way researchers gain insights into eye movements in real-world environments. This year, the eye tracking specialist further raised the bar and introduced SMI Eye Tracking Glasses 2.0 with a new Samsung Galaxy smartphone recorder. And besides academic and commercial research, there are fascinating new applications for SMI's mobile eye tracking glasses by combining gaze interaction with a new generation of head-mounted displays as Google Glass and others.

Using the eyes to interact with games, consumer and industrial applications creates entirely new user experiences. SMI's flexible  contact free eye tracking platform has gained the confidence of global players who seek to integrate gaze interaction technology into consumer devices such as tablets and into assistive and industrial applications. Recently, Sony's Magic Labs announced that they use SMI RED-oem eye tracking to develop new gaze interaction game concepts for the PlayStation 4.

"The last 12 months have been remarkably dynamic for SMI. We continued to push the envelope in all directions: New products and technologies, new partners, new applications driving a continuously and profitably growing business. We have very strong networks in the Bay Area and the new office will help us further expand them," says Eberhard Schmidt, Managing Director of SMI. "We are very grateful for the strong interest from customers and the focus and energy of our team to satisfy it."

Learn more about SensoMotoric Instruments (SMI) at

Contact SMI: Stefanie Gehrke, Marcom Manager,, +49(0)172-3808-537

SMI on YouTube:

SMI on Facebook:

SMI on Twitter:

SMI on Flickr:

SMI on Google+:

SOURCE SensoMotoric Instruments GmbH
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PTS, Inc. Acquires A1CNow and Expands Product Portfolio
2. Smithers Quality Assessments Expands Certification Services to Include Pharmaceuticals Industry
3. Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products
4. GSW Launches Multi-Channel Detailing Platform and Expands Closed-Loop Marketing Suite
5. Life Science Company Calbiotech Expands Holdings with Moduline Systems
6. Giant Eagle Expands Specialty Pharmacy with Acquisition, Bringing Treatment Expertise to Customers with Hepatitis C and Organ Transplant Conditions
7. Hologic Expands its Board of Directors with Appointment of Two Independent Directors and Engages Chairman of Mt. Sinai Radiology Department as Scientific Advisor
8. Shanghai Ajinomoto Amino Acid Co., Ltd. Expands Amino Acid Production Capacity
9. Omnicell Expands its Unity Platform to Further Integrate Workflows
10. One of a Kind People Powered CT Donation Program For Lung Cancer Research Expands
11. Edison Expands its Asia-Pac Pharmaceutical Presence with Launch of Coverage of Mesoblast
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... PUNE, India , November 26, ... --> --> ... Research Report" and "Investigation Report on ... 2019 and 2021 forecasts data and ... library. . ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... ... According to an article published November 15th by ABC News, ... in light of the recent terrorist attacks in Paris, other cities are taking extra ... from reaching U.S. soil. Especially around special events that may be high-profile in nature, ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from Hopkinsville, ... prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , The ... medications. In doing so, it could help to prevent potential overdose situations. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
Breaking Medicine News(10 mins):